ArticlePsychological medicine2025
Mid-life outcomes of young people's antisocial behavior: the role of developmental heterogeneity across childhood and adolescence.
Article in Psychological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntisocial behavior (ASB) is relatively common in childhood and adolescence. While it harms victims, perpetrators are at increased risk of disadvantageous adult outcomes. Developmental heterogeneity is well documented; distinctions have been drawn between early-onset persistent, adolescent-onset, and childhood-limited pathways. We examine whether individuals in some pathways face worse mid-life outcomes than others and whether the pattern differs across sexes.
methodsThe 1970 British Cohort Study assessed parent-reported ASB measures at ages 5, 10, and 16. We classified developmental pathways using the Rutter A scale conduct questions. We categorized children scoring in the top 10% of the distribution as showing high ASB, separately at each assessment. Approximately 6000 individuals were classified into low (73%), childhood-limited (11%), adolescent-onset (9%), and early-onset persistent (7%) groups. We tested associations of ASB grouping with age 46 social, economic, and health outcomes, controlling for a range of covariates.
resultsThe childhood-limited group showed little mid-life difficulty. The early-onset persistent and adolescent-onset groups both showed a pattern of worse midlife outcomes for boys and girls.
conclusionsThe results highlight that ASB in young people is not transient and that prevention and treatment during early childhood and adolescence are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.